Avage Approval For Wrinkles Complements Botox Cosmetic, Allergan Says
Allergan is highlighting the complementary nature of its wrinkle cream Avage to the injectable wrinkle therapy Botox Cosmetic following FDA approval of Avage (tazarotene) Sept. 30
You may also be interested in...
FDA should reconsider its policies restricting language in press releases on unapproved drug uses in light of First Amendment rights, the Pharmaceutical Research & Manufacturers of America maintains in comments to the agency
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials